Back to search
Primary Cardiac Lymphoma
Clinical trial pipeline · Data from ClinicalTrials.gov
See which Primary Cardiac Lymphoma trials you may qualify forClinical trial pipeline · Data from ClinicalTrials.gov
See which Primary Cardiac Lymphoma trials you may qualify forNOTE: This is a research study and is not meant to be a substitute for clinical genetic testing. Families may never receive results from the study or may receiv…
The rationale of this study is to provide an overview on PCL (Primary Cardiac Lymphoma) in Italy, trying to shed light on unknown aspects of the disease and on…
Patients treated for DLBCL are at high risk of developing AICD. This adverse event is characterized by irreversible damage to the heart muscle with a loss of ca…
CoRDS, or the Coordination of Rare Diseases at Sanford, is based at Sanford Research in Sioux Falls, South Dakota. It provides researchers with a centralized, i…
The CARTIER study is a randomized, multicenter, open-label clinical trial comparing, in elderly patients with cancer under anti-tumoral treatment, two different…
Study to evaluate the safety and performance of the Edwards EVOQUE Eos mitral valve replacement system
To understand the safety and efficacy of Revlimid® Capsules 2.5 mg and 5 mg (hereinafter referred to as Revlimid) under actual conditions of use in patients wit…
This study will be focused on assessing the molecular, physiological, and emotional correlates of an intensive meditation experience in the context of a retreat…